chr7-144185541-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_198495.3(CTAGE4):āc.2038T>Gā(p.Ser680Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0013 ( 7 hom., cov: 18)
Exomes š: 0.0018 ( 72 hom. )
Failed GnomAD Quality Control
Consequence
CTAGE4
NM_198495.3 missense
NM_198495.3 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: -0.00400
Genes affected
CTAGE4 (HGNC:24772): (CTAGE family member 4) Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport; protein secretion; and vesicle cargo loading. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum exit site and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.007178098).
BP6
Variant 7-144185541-T-G is Benign according to our data. Variant chr7-144185541-T-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2558585.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTAGE4 | NM_198495.3 | c.2038T>G | p.Ser680Ala | missense_variant | 1/1 | ENST00000486333.2 | NP_940897.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTAGE4 | ENST00000486333.2 | c.2038T>G | p.Ser680Ala | missense_variant | 1/1 | NM_198495.3 | ENSP00000419539 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00127 AC: 164AN: 129130Hom.: 7 Cov.: 18
GnomAD3 genomes
AF:
AC:
164
AN:
129130
Hom.:
Cov.:
18
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000950 AC: 183AN: 192712Hom.: 20 AF XY: 0.000990 AC XY: 104AN XY: 105008
GnomAD3 exomes
AF:
AC:
183
AN:
192712
Hom.:
AF XY:
AC XY:
104
AN XY:
105008
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00181 AC: 2537AN: 1403150Hom.: 72 Cov.: 31 AF XY: 0.00174 AC XY: 1213AN XY: 698650
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
2537
AN:
1403150
Hom.:
Cov.:
31
AF XY:
AC XY:
1213
AN XY:
698650
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00127 AC: 164AN: 129188Hom.: 7 Cov.: 18 AF XY: 0.00112 AC XY: 70AN XY: 62708
GnomAD4 genome
AF:
AC:
164
AN:
129188
Hom.:
Cov.:
18
AF XY:
AC XY:
70
AN XY:
62708
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
113
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 04, 2023 | The c.2038T>G (p.S680A) alteration is located in exon 1 (coding exon 1) of the CTAGE4 gene. This alteration results from a T to G substitution at nucleotide position 2038, causing the serine (S) at amino acid position 680 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | CTAGE4: BP4, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
ClinPred
T
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at